Filgrastim Dosing for ANC 0.61 × 10⁹/L
Administer filgrastim 5 mcg/kg/day subcutaneously and continue daily until the ANC reaches 2-3 × 10⁹/L. 1
Dosing Algorithm
Based on ASCO clinical practice guidelines, the standard approach for treating established neutropenia with filgrastim follows this protocol:
- Dose: 5 mcg/kg per day for adults 1
- Route: Subcutaneous injection (preferred) 1
- Duration: Continue daily administration until ANC recovers to 2-3 × 10⁹/L 1
- Timing: Can be started immediately given the current neutropenic state
Clinical Context
Your patient's ANC of 0.61 × 10⁹/L represents grade 3 neutropenia (ANC 0.5-1.0 × 10⁹/L), placing them at increased risk for infection. The guideline-recommended target for discontinuation is ANC 2-3 × 10⁹/L, which typically takes 12-16 days to achieve with filgrastim therapy 2.
Key Monitoring Parameters
Monitor ANC daily during treatment. Research demonstrates that:
- ANC nadir typically occurs 5-7 days after chemotherapy 3
- Recovery to target levels occurs in a median of 16 days with filgrastim versus 23 days without 2
- Critical neutropenia duration is reduced from 4 days to 3 days with filgrastim 4
Important Caveats
Do not discontinue prematurely: The depth of nadir inversely correlates with recovery duration 3. Stopping filgrastim before ANC reaches 2-3 × 10⁹/L increases risk of recurrent neutropenia.
Watch for excessive response: If ANC exceeds 20 × 10⁹/L, reduce dose by 50% or temporarily discontinue 1. However, WBC counts >100,000/mm³ occur in <5% of patients and are not associated with adverse clinical effects 5.
Bone pain management: This is the most common side effect (occurring in ~5% of patients) and responds to standard analgesics 6.
Alternative Consideration
If daily injections pose adherence challenges, pegfilgrastim 6 mg as a single dose could be considered for future cycles, though this is typically used for prophylaxis rather than treatment of established neutropenia 1.